← NovoCure Ltd
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | ($131.8m) |
($61.7m)
+53.23%
|
($63.6m)
-3.08%
|
($7.2m)
+88.62%
|
$19.8m
+373.97%
|
($58.4m)
-394.58%
|
($92.5m)
-58.58%
|
($207.0m)
-123.75%
|
($168.6m)
+18.55%
|
($136.2m)
+19.21%
|
— | |
| Depreciation and amortization | $5.7m | $7.7m | $9.0m | $8.5m | $9.2m | $10.3m | $10.6m | $11.0m | $11.2m | $14.7m | $16.3m | |
| Depreciation | $1.7m | $2.0m | $2.0m | $2.1m | $2.6m | $2.8m | $3.1m | $3.9m | $6.2m | $9.4m | $13.1m | |
| Amortization of Debt Issuance Costs | $667k | $1.1m | $2.8m | $156k | — | — | — | — | — | — | — | |
| Amortization of Debt Issuance Costs and Discounts | — | — | — | — | $4.5m | $3.3m | $3.3m | $3.3m | $2.6m | $3.6m | — | |
| Capitalized Computer Software, Amortization | $731k | $1.2m | $1.5m | $1.7m | $1.4m | $1.1m | $1.1m | $1.3m | $1.4m | $1.5m | — | |
| Deferred Income Tax Expense (Benefit) | $17k | ($354k) | $348k | $144k | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Share-based Payment Arrangement, Noncash Expense | $22.1m | $27.1m | $39.8m | $52.4m | $75.7m | $94.9m | $107.0m | $115.6m | $160.0m | $104.8m | $129.2m | |
| Share-based Payment Arrangement, Expense | $21.4m | $27.1m | $39.8m | $52.4m | $75.7m | $94.9m | $107.0m | $115.6m | $160.0m | $104.8m | $129.2m | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | $6.3m | $23.2m | $4.2m | $36.5m | $30.4m | ($5.3m) | ($2.5m) | ($29.4m) | ($26.4m) | ($38.9m) | ($18.6m) | |
| Increase (Decrease) in Inventories | $12.0m | ($3.5m) | $529k | $1.2m | $2.9m | ($2.5m) | $4.3m | $8.9m | ($2.6m) | $5.7m | ($3.0m) | |
| Inventory Write-down | $774k | $489k | $684k | $310k | $616k | $1.0m | $917k | $681k | $756k | $5.7m | — | |
| Net Cash Provided by (Used in) Operating Activities | ($107.6m) |
($33.1m)
+69.20%
|
($1.9m)
+94.37%
|
$26.6m
+1527.35%
|
$99.1m
+272.46%
|
$82.8m
-16.53%
|
$30.8m
-62.80%
|
($73.3m)
-338.20%
|
($26.4m)
+64.04%
|
($49.0m)
-85.94%
|
($2.8m)
+94.26%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $5.7m | $2.5m | $2.9m | $10.5m | $15.0m | $24.2m | $21.4m | $27.1m | $42.9m | $26.6m | ($22.6m) | |
| Net Cash Provided by (Used in) Investing Activities | $12.8m | $6.8m | ($5.5m) | ($51.7m) | ($472.8m) | ($144.8m) | ($140.0m) | $184.1m | ($140.2m) | $437.3m | $409.1m | |
| Cash flows from financing activities: | ||||||||||||
| Repayments of Long-term Debt | — | — | $100.0m | $31k | $150.0m | $26k | $28k | $10k | $12.9m | $560.9m | ($560.9m) | |
| Proceeds from Issuance of Long-term Debt | $72.9m | — | $149.2m | $0 | $558.4m | — | — | — | $96.9m | $100.0m | $100.0m | |
| Proceeds from Issuance of Common Stock | $616k | $1.5m | $1.8m | $2.5m | $3.4m | $4.5m | $5.2m | $4.4m | $4.2m | $3.7m | $3.6m | |
| Dividends paid | $0 | $0 | — | — | — | — | — | — | — | — | — | |
| Net Cash Provided by (Used in) Financing Activities | $75.1m |
$5.2m
-93.12%
|
$69.4m
+1242.28%
|
$61.7m
-11.08%
|
$440.2m
+613.69%
|
$25.7m
-94.16%
|
$15.5m
-39.73%
|
$15.8m
+1.91%
|
$90.3m
+472.08%
|
($451.3m)
-599.74%
|
($454.6m)
-0.72%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $10k | $8k | $27k | $36.7m | $66.8m | ($36.6m) | ($93.8m) | $126.7m | ($76.5m) | ($62.7m) | $103.9m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $10k | $8k | $142.8m | $179.4m | $246.2m | $209.6m | $115.8m | $242.6m | $166.1m | $103.4m | $103.9m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $10k | $8k | $27k | $26k | $247k | ($188k) | ($97k) | $131k | ($174k) | $394k | ($236k) | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | — | — | $18.5m | $59.2m | $28.4m | $21.2m | $10.3m | $11.4m | $2.2m | $6.1m | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $6.6m | $10.2m | $13.3m | $13.7m | $8.7m | $101k | $41k | $6k | $7.7m | $13.4m | — | |
| Income Taxes Paid, Net | $9.4m | $10.3m | $20.4m | $11.2m | ($3.3m) | $3.1m | $5.5m | $13.7m | $23.5m | $30.7m | — | |
| Additional Financial Items | ||||||||||||
| Foreign Currency Transaction Gain (Loss), before Tax | — | $0 | $0 | $917k | $699k | ($3.2m) | $3.3m | ($161k) | $227k | ($1.3m) | — | |
| General and Administrative Expense | $51.0m | $59.1m | $73.5m | $87.9m | $107.4m | $126.1m | $132.8m | $164.1m | $189.8m | $177.7m | — | |
| Income Tax Expense (Benefit) | $10.4m | $13.2m | $17.6m | ($1.6m) | ($1.7m) | $6.3m | $10.7m | $15.3m | $37.5m | ($23k) | — | |
| Investment Income, Interest | $659k | $1.1m | $2.7m | $4.4m | $1.8m | $791k | $11.0m | $19.6m | $22.7m | $12.9m | — | |
| Operating Expenses | $151.9m | $160.7m | $201.7m | $263.6m | $357.5m | $464.5m | $512.5m | $613.9m | $638.5m | $642.3m | — | |
| Operating Lease, Expense | — | — | — | — | $6.0m | $7.3m | $7.1m | $8.2m | $9.2m | $12.0m | — | |
| Pension Cost (Reversal of Cost) | $529k | $1.0m | $882k | $984k | $1.6m | $1.5m | $2.1m | $2.7m | $3.9m | $3.9m | — | |
| Restructuring Costs | — | — | — | — | — | — | — | $6.2m | $2.0m | $0 | — |